Autolus Therapeutics to Report Third Quarter 2020 Financial Results and Host Conference Call on November 5GlobeNewsWire • 10/30/20
Autolus Therapeutics presents additional data on AUTO3 in DLBCL during the ESMO Virtual Congress 2020GlobeNewsWire • 09/18/20
Autolus Therapeutics to host Investor Conference Call to discuss AUTO3 data presented at ESMO and to participate in Banking conferences through SeptemberGlobeNewsWire • 09/08/20
Autolus Therapeutics PLC (AUTL) CEO Christian Itin on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Autolus Therapeutics Reports Second Quarter 2020 Financial Results and Operational ProgressGlobeNewsWire • 08/06/20
Autolus Therapeutics presents new preclinical data during the Virtual 2020 AACR Annual MeetingGlobeNewsWire • 06/22/20
Is Autolus Therapeutics PLC Sponsored (AUTL) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 06/19/20
Autolus Therapeutics presents AUTO1 and AUTO3 data at the 2020 EHA25 Virtual CongressGlobeNewsWire • 06/12/20
Autolus Therapeutics PLC Sponsored ADR (AUTL) Upgraded to Strong Buy: What Does It Mean for the Stock?Zacks Investment Research • 05/12/20
Autolus Therapeutics Plc (AUTL) CEO Christian Itin on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
Autolus Therapeutics Announces FDA Acceptance of IND Application for AUTO1 for Adult Acute Lymphoblastic LeukemiaGlobeNewsWire • 04/16/20
Autolus Therapeutics (AUTL) CEO Christian Itin on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 03/03/20
Autolus Therapeutics Presents Encouraging Additional Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood CancersGlobeNewsWire • 01/30/20
Autolus Therapeutics Announces New Data Showcasing Clinical Progress of AUTO3 in B Cell MalignanciesGlobeNewsWire • 12/08/19
Autolus Therapeutics Announces New Data Showcasing Clinical Progress of Programmed T Cell Therapy Pipeline in Blood CancersGlobeNewsWire • 12/07/19